Randomised clinical non-inferiority trial comparing two formulations of desoxycortone pivalate for the treatment of canine primary hypoadrenocorticism

BACKGROUND: This clinical trial compared two formulations of desoxycortone pivalate (DOCP) for treating the mineralocorticoid deficit in dogs with primary hypoadrenocorticism (PH). METHODS: At veterinary clinics in the USA and France, dogs with PH (n=152) were randomised (3:1) to receive approximate...

Descripción completa

Detalles Bibliográficos
Autores principales: Farr, Hayley, Mason, Beasley L, Longhofer, Susan L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Electronic Pages
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456700/
https://www.ncbi.nlm.nih.gov/pubmed/31974265
http://dx.doi.org/10.1136/vr.105328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456700/
https://www.ncbi.nlm.nih.gov/pubmed/31974265
http://dx.doi.org/10.1136/vr.105328

Ejemplares similares